The Practice Healthcare in Beverly Hills Launches Hyperbaric Oxygen Therapy Program This April

AprilAire Introduces Patented Healthy Air Intelligence™ in New Air Monitor for the Home

Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting

Centene Announces New Executive Leadership Structure

Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

Innocan Pharma Announces Closing of Additional Debenture

MEDIPEEL gewinnt an Dynamik im koreanischen K-Pharma-Kanal

K-679: Un nouveau conjugué d'anticorps chargé de Unimicelle présente une pharmacocinétique sélective de la tumeur , une distribution intratumorale étendue et une efficacité supérieure dans les modèles animaux non cliniques.

K-679: Ein neuartiges, mit Antikörpern beladenes Unimicelle-Konjugat zeigt Tumor-selektive Pharmakokinetik, weitreichende intratumorale Verteilung und überlegene Wirksamkeit in nicht-klinischen Tiermodellen

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models

Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

MEDIPEEL gana impulso en el canal de farmacias coreanas

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology

Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE

SirPAD: Primäre Ergebnisse bestätigen die Sicherheit und Wirksamkeit des mit Sirolimus beschichteten Ballons bei peripherer arterieller Verschlusskrankheit (Peripheral Arterial Disease, PAD)

PPMW responds to 5th Circuit Court ruling on Mifepristone access

Zibu AI Aims to Transform Patient Communication with AI-Powered Voice Agent

La sexta Conferencia de Misión del IEHP alcanza una 'nota alta' de temática musical

SetPoint Medical to Participate at the Bank of America Health Care Conference

Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)

Viatris Announces Chief Financial Officer Transition

BulletinHealthcare Relaunches The Daily in Collaboration with the Medical Society of the State of New York

NHI Issues Investor Update

Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update

NHI Announces First Quarter 2026 Results

Valion Bio Appoints Melinda Lackey as General Counsel